| Literature DB >> 32354172 |
Jeannett A Izquierdo-Vega1, Diego A Arteaga-Badillo1, Manuel Sánchez-Gutiérrez1, José A Morales-González2, Nancy Vargas-Mendoza2, Carlos A Gómez-Aldapa3, Javier Castro-Rosas3, Luis Delgado-Olivares1, Eduardo Madrigal-Bujaidar4, Eduardo Madrigal-Santillán2.
Abstract
Roselle (Hibiscus sabdariffa L.), also known as jamaica in Spanish, is a perennial plant that grows in tropical and subtropical regions, including China, Egypt, Indonesia, Mexico, Nigeria, Thailand, and Saudi Arabia. It has a long history of uses, mainly focused on culinary, botanical, floral, cosmetic, and medicinal uses. The latter being of great impact due to the diuretic, choleretic, analgesic, antitussive, antihypertensive, antimicrobial, immunomodulatory, hepatoprotective, antioxidant, and anti-cancer effects. These therapeutic properties have been attributed to the bioactive compounds of the plant, mainly phenolic acids, flavonoids, anthocyanins, and organic acids (citric, hydroxycitric, hibiscus, tartaric, malic, and ascorbic). Most literature reviews and meta-analyses on the therapeutic potential of Hibiscus sabdariffa L. (Hs) compounds have not adequately addressed the contributions of its organic acids present in the Hs extracts. This review compiles information from published research (in vitro, in vivo, and clinical studies) on demonstrated pharmacological properties of organic acids found in Hs. The intent is to encourage and aid researchers to expand their studies on the pharmacologic and therapeutic effects of Hs to include assessments of the organic acid components.Entities:
Keywords: Hibiscus sabdariffa L.; citric acid; hibiscus acid; hydroxycitric acid; malic acid; pharmacological effects; roselle
Year: 2020 PMID: 32354172 PMCID: PMC7277581 DOI: 10.3390/biomedicines8050100
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059
Figure 1Therapeutic and/or pharmacological properties of Hibiscus sabdariffa L. extracts.
Nutritional compounds of Hibiscus sabdariffa L.
| Nutritional Compound | Calyxes (mg) | Fresh Leaves (%) | Seed (%) |
|---|---|---|---|
| Humidity | 9.2 | 26.2 | 12.9 |
| Proteins | 1.145 | 1.7–3.2 | 3.29 |
| Fat | 2.61 | 1.1 | |
| Carbohydrates | 10 | ||
| Fatty oil | 12.9 | ||
| Celullose | 12.9 | ||
| Pentoses | 15.8 | ||
| Starch | 11.1 | ||
| Fiber | 12 | ||
| Calcium | 1.263 | 0.18 | |
| Phosphorus | 273.2 | 0.04 | |
| Iron | 8.98 | 0.0054 | |
| Thiamine | 0.117 | ||
| Riboflavin | 0.277 | ||
| Niacin | 3.765 | ||
| Ascorbic acid | 6.7 | ||
| Malic acid | 1.25 |
Nutritional compounds in 100 g of roselle [15].
Therapeutic effects and concentrations of some bioactive compounds from extracts of Hibiscus sabdariffa L. calyxes.
| Extract Type | Bioactive Compound | Concentrations | Therapeutic Effect Evaluated |
|---|---|---|---|
|
| |||
| Aqueus | Delphinidin-3-sambubioside | 2701.21 ± 165.55 ppm | Antioxidant, anti-inflammatory, antidiabetic, antiparasitic, antimicrobial, anti-cancer, apoptosis, anti-atherosclerotic, antilipidemic, antihypertensive, obesity, diuretic, hepatoprotective, antimutagenic and immunomodulatory [ |
| Delphinidin-3-sambubioside | 0.78 mg/g | ||
| Ethanolic | Delphinidin-3-sambubioside | 7.03 ± 0.04 mg/g | |
| Aqueous | Cyanidine-3-sambubioside | 1939.15 ± 39.27 ppm | |
| Cyanidine-3-sambubioside | 0.46 mg/mL | ||
| Ethanolic | Cyanidine-3-sambubioside | 4.40 ± 0.02 mg/mL | |
|
| |||
| Aqueous | Chlorogenic acid | 1923.72 ± 38.69 ppm | Antioxidant, anti-inflammatory, antidiabetic, antiparasitic, antimicrobial, anti-cancer, apoptosis, anti-atherosclerotic, antilipidemic, antihypertensive, obesity, diuretic, hepatoprotective, antimutagenic and immunomodulatory [ |
| Chlorogenic acid isomer I | 2755.15 ± 62.42 ppm | ||
| Chlorogenic acid isomer II | 1041.19 ± 16.96 ppm | ||
| Aqueous | 5-O-Caffeoyl-shikimic acid | 171.47 ± 6.92 ppm | |
| 3-Caffeoylquinic acid | 0.36 mg/mL | ||
| Ethanolic | 3-Caffeoylquinic acid | 2.6 mg/g | |
| Aqueous | 5-Caffeoylquinic acid | 0.30 mg/mL | |
| Ethanolic | 5-Caffeoylquinic acid | 1.53 ± 0.06 mg/g | |
| Aqueous | 4-Caffeoylquinic acid | 1.44 ± 0.08 mg/g | |
| 4-Caffeoylquinic acid | 1.00 ± 0.02 mg/g | ||
| Methanolic | Caffeic acid | 18.24% | |
| Protocatechuic acid | 8.62% | ||
| Aqueous | Quercetin | 121.24 ± 2.01 ppm | |
| Quercetin-3-sambubioside | 304.02 ± 5.90 ppm | ||
| Aqueous | Quercetin-3-rutinoside | 495.76 ± 4.34 ppm | |
| Ethanolic | Quercetin-3-rutinoside | 1.07 ± 0.1 mg/g | |
| Aqueous | Quercitin-3-glucoside | 143.74 ± 2.16 ppm | |
| Ethanolic | Quercetin-pentosylhexoside | 1.031 ± 0.002 mg/g | |
| Ethanolic | Myricetin-pentosylhexoside | 0.961 ± 0.001 mg/g | |
|
| |||
| Aqueous | Hibiscus acid (HA) | 31122.02 ± 1128.39 ppm (13–24%). | Antimicrobial, antidiabetic antihypertensive/vasorelaxant, [ |
| Hydroxycitric acid (HCA) | 8288.03 ± 397.63 ppm | Antioxidant, anti-inflammatory, obesity, neuroprotective agent, antilipidemic, [ | |
| Citric acid (CA) | 12–20% | Anticoagulant, antioxidant, anti-inflammatory [ | |
| Malic acid | 2–9% | Exfoliating agent, apoptosis, treatment of xerostomy, antiproliferative agent [ | |
| Tartaric acid | 8% | Natural acidifying [ | |
| Ascorbic acid | 0.02–0.05% | Antioxidant [ | |
Figure 2Chemical structure of the main organic acids of Hs. (A) Citric acid, (B) Hydroxycitric acid, and (C) Hibiscus acid [3,16].
Main applications of citric acid.
| Industry | Applications |
|---|---|
| Canned and/or preserved foods | From fruits and vegetables (lettuce, carrot, celery, spinach, paprika, mushrooms) to beef, chicken and fish; CA monohydrate (food additive E330) lowers the pH, acts as a chelator and prevents enzymatic oxidation avoiding the degradation of food color and taste |
| Dairy products | CA-E330 is an important stabilizer of whipped creams to maintain their texture. It is an acidifying agent in many cheese products and as an antioxidant. |
| Cake shop | The main function of the CA-E330 is acidulant. In general, it acts on the conservation, viscosity, and acidity of gels, cakes and/or cupcakes |
| Beverages | It provides acidity and complements the flavors of fruits and berries. Increases the effectiveness of antimicrobial preservatives and adjusts the pH to maintain a uniform acidity. |
| Jellies, jams, and preserves | Provides acidity and regulates the pH of the products |
| Pharmaceuticals | As effervescent in powders and tablets in combination with bicarbonates. Provides rapid dissolution of active ingredients. Acidulant in mild astringent formulation. Anticoagulant. |
| Cosmetics and toiletries | pH adjustment, antioxidant as a metallic-ion chelator, buffering agent. |
| Metal cleaning | Cleans and removes iron and copper oxides from surfaces of ferrous and nonferrous metals |
| Others | Also used in the copper plating, leather tanning, printing inks, bottle washing compounds, textiles, photographic reagents, moulds, adhesives, polymers, and waste treatment |
Main therapeutic evidence of Hydroxycitric acid.
| Year | Authors | Main Objective, Results, and Conclusion | References |
|---|---|---|---|
| 2003 | Hayamizu et al. | Evaluation of oral administration of | [ |
| 2007 | Preuss et al. | The effect of HCA alone and combined with chromium plus niacin (NBC) on weight loss was analyzed in this clinical study. After 8 weeks of administering the compounds to 60 moderately obese subjects, a significant decrease in body weight, BMI and total cholesterol concentrations, low density lipoproteins, and triglycerides was observed. Their results suggested that the combination of HCA-chromium-NBC may be an effective formula for losing weight and promoting healthy blood lipid levels. | [ |
| 2009 | Carvajal-Zarrabal et al. | The objective was to analyze the effect of three ethanolic extracts of Hs dry calyx on fat absorption-excretion and body weight in Sprague-Dawley rats. One group of animals was fed a normal diet and others with the same diet plus the supplement of each extract [5% (Hs5), 10% (Hs10) and 15% (Hs15)]. Only Hs5 showed no changes in weight and food consumption; unlike the group treated with Hs15 where there was a significant decrease in these parameters and a greater amount of fatty acids found in the feces. It was concluded that this anti-obesity effect is possibly attributed to the presence of the HCA from the extracts. | [ |
| 2012 | Márquez et al. | Information was collected from different authors confirming that the administration of G. cambogia extracts (where HCA is found) is associated with weight reduction and fat loss. However, these Spanish researchers suggest to be cautious when interpreting the results, as there are conflicting data in some randomized and controlled clinical trials. In addition, they indicate that the majority of human studies have been conducted in small samples and mainly in the short term. None of them have demonstrated whether these effects persist beyond 12 weeks of intervention. There is little evidence on the long-term benefits of extracts, and especially HCA. Regarding its toxicity, they suggest considering the evidence that HCA can cause acute skin lesions if applied directly to the skin, cause eye irritation and increase the level of peripheral testosterone by stimulating erythropoiesis in humans. Also, it is important to consider that, during fetal development, there is a high demand for lipid production for growth and that the lipids produced by the mother are transferred through the placenta to the fetus; therefore, possibly the HCA by inhibiting the synthesis and storage of lipids may be critical for gestational development. | [ |
| 2016 | Goudarzvand et al. | The study evaluated the administration of HCA (2 g/kg/day for 3 weeks) in C57BL/6 mice with multiple sclerosis. At the end of the period the treatment improved the symptoms of nerve injury, decreasing the levels of serum interleukin-6 (IL-6), TNF-α, MDA, and nitric oxide (NO). It was also observed that the activity of superoxide dismutase (SOD) and glutathione reductase (GR) increased; in consequence, HCA may have neuroprotective effects through anti-inflammatory and antioxidant mechanisms | [ |
| 2019 | Han et al. | To assess the effects of the long-term supplement with HCA on weight gain and variations in amino acid content in rats. Significant loss of body weight and increased thyroid hormone levels were observed. These results suggest that HCA promotes energy expenditure by regulating thyroid hormone levels. In addition, it possibly stimulates protein synthesis by altering the metabolic directions of amino acids. | [ |
| 2019 | Ibuki et al. | It is known that age-related macular degeneration (AMD) is the leading cause of blindness. Likewise, different evidence have established that the anti-vascular endothelial growth factor (VEGF) therapy has a potent therapeutic effect against the disease. There is the possibility of presenting different systemic adverse events, such as chorio-retinal atrophy, due to the long-term antagonism of VEGF. The objective of this study was to explore the effect of HCA on the hypoxia-inducible factor (HIF) regulation of VEGF transcription. At the end of the study, it was confirmed that HCA showed an inhibitory effect on HIF in the luciferase assay. | [ |
| 2019 | Tomar et al. | It was a clinical and computational study (100 individuals under a 3-month treatment) on the anti-obesity effects of HCA. Anthropometric parameters and plasma lipid profiles were evaluated. A hepatic metabolic model was used to incorporate the effect of HCA at the level of the metabolic pathway. In addition, the activity of ATP citrate lyase in the metabolic pathway was analyzed to simulate the net effect of HCA. The results showed a reduction in the synthesis of fatty acids, triglycerides and cholesterol. It was concluded that treatment with HCA can reduce body weight gain and fat accumulation in obese subjects along with the improvement of their anthropometric parameters and metabolic status. | [ |